Treasury Board of Canada Secretariat
Symbol of the Government of Canada

 

ARCHIVED - Patented Medicine Prices Review Board - Supplementary Tables

Warning This page has been archived.

Archived Content

Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.





2012-13
Report on Plans and Priorities



Patented Medicine Prices Review Board





Supplementary Information (Tables)





Table of Contents




Green Procurement Reporting For Departments and Agencies Not Bound by the Federal Sustainable Development Act


Departments and agencies bound by the Policy on Green Procurement but not the Federal Sustainable Development Act must complete mandatory reporting on meeting the requirements of Section 7 of the Policy on Green Procurement using this section5.
Performance Measure RPP DPR
Policy Implementation Status (Optional) N/A

Strategies / Comments

  1. Approach: The PMPRB’s approach to implementing green procurement is targeted to the use of PWGSC procurement instruments, ensuring key procurement personnel are trained and including green procurement objectives in the employee performance evaluations of key decision makers.
  2. Management Processes and Controls: The PMPRB uses PWGSC procurement instruments as its primary procurement mechanism and leverages the environmental considerations incorporated into these standing offers.  Furthermore:
    • Since 2010-11, the PMPRB has been following the Federal Electronic Waste Strategy for surplus electronic and electrical equipment ; and
    • Since 2011-12, all contracting documents include a clause addressing environmental considerations in the performance of the work required.
  3. Setting Targets: In addition to the commitments identified in ii., v., and vi., the PMPRB will continue to ensure that 95% of all purchases are made through PWGSC green consolidated procurement instruments, where available.
  4. Training: Senior management will also increase staff awareness of environmental issues, such as limiting the number of colour copies and printed copies of documents to only what is necessary and using two-sided printing and copying where feasible.
  5. Performance Evaluations: Include in each Chief or Unit Head in Corporate Services Branch with responsibility for procurement, an objective in his/her performance management agreement to ensure environmental considerations are taken into account in all procurement activities.
  6. Meeting Targets: The PMPRB will report against these targets in the Departmental Performance Report.



Sources of Non-Respendable Revenue


Program Activity ($ thousands)
Forecast
Revenue
2011-12		 Planned
Revenue
2012-13		 Planned
Revenue
2013-14		 Planned
Revenue
2014-15
 Patented Medicines Price Regulation Program
Voluntary Compliance Undertakings $10,907.01  - - -
Refunds of amounts credited to revenues in previous years (2,512.9)2      
Total Non-respendable Revenue $8,394.1  - - -

  • 1 The money reported as non-respendable revenue does not represent revenues generated by the PMPRB. This money is a result of payments made by patentees to the Government of Canada through Voluntary Compliance Undertakings (VCUs) or Board orders to offset excess revenues. The Minister of Health may enter into agreements with any province or territory respecting the distribution to that province/territory of amounts received by the Receiver General, less any costs incurred in relation to the collection and distribution of those amounts.

  • 2 Following a hearing of the Board conducted in 2008-2009 pursuant to the Patent Act, the Board concluded that the patentee had sold two patented medicines in Canada at excessive prices. The patentee was ordered by the Board to pay the amount of $2,512.9 thousand to the Crown. The patentee complied with the Board Order but applied for judicial review of the Order. The Federal Court quashed the Board Order and directed in its judgment that the sum of $2,512.9 thousand be returned promptly to the patentee with appropriate interest and specified costs.



Upcoming Internal Audits and Evaluations over the next three fiscal years

A. All upcoming Internal Audits over the next three fiscal years


Name of Internal Audit Internal Audit Type Status Expected Completion Date
Horizontal Audit of Integrated Business and Human Resources Planning in Small Departments and Agencies Integrated business and human resources planning activities. In-progress Fall 2012
Audit by the Public Service Commission of Canada Organizational Audit of the delegated staffing system Planned 2013

B. All upcoming Evaluations over the next three fiscal years


Name of Evaluation Program Activity Status Expected Completion Date
Evaluation of the PMPRB’s Programs

Program Activity 1:
Patented Medicines Price Regulation Program

Program Activity 2:
Pharmaceutical Trends Program

 In-progress Final Report – Spring 2012